The interview with Allan Kohler highlighted SPT is well behind other players and share price was we’ll overvalued. No surprise it’s being sold off now as reality sets in
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025